Randomised phase II trial of first-line docetaxel, carboplatin, capecitabine (CTX) and epirubicin, oxaliplatin, capecitabine (EOX) in advanced esophagogastric adenocarcinoma (SEED)

被引：0
|
作者：
Petersen, P. C. [1 ]
Petersen, L. Noergaard [1 ]
Vogelius, I. R. [1 ]
Bjerregaard, J. K. [1 ]
Baeksgaard, L. [1 ]
机构：
[1] Rigshosp, Dept Oncol, Copenhagen, Denmark
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
796P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A randomized phase 2 trial of first-line docetaxel, carboplatin, capecitabine (CTX) and epirubicin, oxaliplatin, capecitabine (EOX) in advanced esophagogastric adenocarcinoma
    Petersen, Peter C.
    Petersen, Lone N.
    Vogelius, Ivan
    Bjerregaard, Jon K.
    Baeksgaard, Lene
    [J]. ACTA ONCOLOGICA, 2021, 60 (07) : 948 - 953
  • [2] Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as Palliative First-line Chemotherapy for Gastroesophageal Adenocarcinoma
    Pluschnig, Ursula
    Schoppmann, Sebastian F.
    Preusser, Matthias
    Datler, Philip
    Asari, Reza
    Ba-Ssalamah, Ahmed
    Schwameis, Katrin
    Birner, Peter
    Zacherl, Johannes
    Hejna, Michael
    [J]. ANTICANCER RESEARCH, 2013, 33 (03) : 1035 - 1039
  • [3] A Phase II Trial of Epirubicin, Oxaliplatin, and Capecitabine (EOX) as First-Line Chemotherapy in Advanced Gastric Cancer: A Chinese Single-Center Experience
    Xiang, Xiao Jun
    Qiu, Feng
    Xiong, Jian Ping
    Zhang, Ling
    Yu, Feng
    Feng, Miao
    Zhan, Zheng Yu
    [J]. CHEMOTHERAPY, 2010, 56 (03): : 171 - 177
  • [4] Phase III trial comparing XELOX regimen (oxaliplatin plus capecitabine) versus EOX regimen (epirubicin, oxaliplatin and capecitabine) as first-line treatment for advanced gastric cancer: EXELOX trial.
    Guo, Weijian
    Zhu, Xiaodong
    Huang, Mingzhu
    Wang, Yusheng
    Chen, Zhiyu
    Feng, Wanjing
    He, Yifu
    Zhang, Xiaowei
    Liu, Xin
    Wang, Chenchen
    Zhang, Wen
    Ying, Jieer
    Wu, Jun
    Yang, Lei
    Qin, Yanru
    Zhao, Xiaoying
    Li, Wenhua
    Zhang, Zhe
    Qiu, Lixin
    Wang, XiaoFeng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] A randomized phase II trial comparing capecitabine with oxaliplatin or docetaxel as first-line treatment in advanced gastric and gastroesophageal adenocarcinomas
    Ni, Lu
    Zhang, Weihan
    Chen, Ye
    Leng, Weibing
    Gou, Hongfeng
    Hu, Jiankun
    Qiu, Meng
    [J]. MEDICINE, 2021, 100 (17) : E25493
  • [6] Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma:: a prospective multicentre phase II trial
    Nehls, O.
    Oettle, H.
    Hartmann, J. T.
    Hofheinz, R-D
    Hass, H. G.
    Horger, M. S.
    Koppenhoefer, U.
    Hochhaus, A.
    Stieler, J.
    Trojan, J.
    Gregor, M.
    Klump, B.
    [J]. BRITISH JOURNAL OF CANCER, 2008, 98 (02) : 309 - 315
  • [7] Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial
    O Nehls
    H Oettle
    J T Hartmann
    R-D Hofheinz
    H G Hass
    M S Horger
    U Koppenhöfer
    A Hochhaus
    J Stieler
    J Trojan
    M Gregor
    B Klump
    [J]. British Journal of Cancer, 2008, 98 : 309 - 315
  • [8] Comparison Between DCF (Docetaxel, Cisplatin and 5-Fluorouracil) and Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as Palliative First-line Chemotherapy for Adenocarcinoma of the Upper Gastrointestinal Tract
    Ilhan-Mutlu, Ayseguel
    Preusser, Matthias
    Schoppmann, Sebastian F.
    Asari, Reza
    Ba-Ssalamah, Ahmed
    Schwameis, Katrin
    Pluschnig, Ursula
    Birner, Peter
    Puespoek, Andreas
    Zacherl, Johannes
    Hejna, Michael
    [J]. ANTICANCER RESEARCH, 2013, 33 (08) : 3455 - 3459
  • [9] Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer
    Zeuli, M
    Nardoni, C
    Pino, MS
    Gamucci, T
    Gabriele, A
    Ferraresi, V
    Giannarelli, D
    Cognetti, F
    [J]. ANNALS OF ONCOLOGY, 2003, 14 (09) : 1378 - 1382
  • [10] Docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer: A phase II study
    Evans, Devon
    Miner, Thomas
    Iannitti, David
    Akerman, Paul
    Cruff, Dennis
    Maia-Acuna, Christine
    Harrington, David
    Habr, Fadlo
    Chauhan, Bharti
    Berkenblit, Anna
    Stuart, Keith
    Sears, Dina
    Kennedy, Teresa
    Safran, Howard
    [J]. CANCER INVESTIGATION, 2007, 25 (06) : 445 - 448
12345